Known Benefits and Unknown Risks of Active Surveillance of Cervical Intraepithelial Neoplasia Grade 2

Autor: Kathrine D. Lycke, Lone K. Petersen, Patti E. Gravitt, Anne Hammer

Publikováno v: Lycke, K D, Petersen, L K, Gravitt, P & Hammer, A 2022, ' Known Benefits and Unknown Risks of Active Surveillance of Cervical Intraepithelial Neoplasia Grade 2 ', Obstetrics and Gynecology . https://doi.org/0.1097/AOG.0000000000004705
Lycke, K D, Petersen, L K, Gravitt, P E & Hammer, A 2022, ' Known Benefits and Unknown Risks of Active Surveillance of Cervical Intraepithelial Neoplasia Grade 2 ', Obstetrics and Gynecology, vol. 139, no. 4, pp. 680-686 . https://doi.org/10.1097/AOG.0000000000004705
Lycke, K D, Kjeld Petersen, L, Gravitt, P & Hammer, A 2022, ' Known benefits and unknown risks of active surveillance of cervical intraepithelial neoplasia grade 2 ', Obstetrics and Gynecology, vol. 139, no. 4, pp. 680-686 . https://doi.org/10.1097/AOG.0000000000004705

Cervical intraepithelial neoplasia grade 2 (CIN 2) is an equivocal diagnosis with high interobserver variation. Owing to high regression rates of 50%, many countries recommend active surveillance of CIN 2, especially in women younger than age 25-30 y

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::335e1a26e21997e871eb23a7fb0e7914
https://doi.org/10.1097/aog.0000000000004705